je.st
news
Will Q4 Earnings Prove A Shot In The Arm For Questcor Pharmaceuticals?
2014-02-14 14:49:59| Biotech - Topix.net
Its primary product is H.P. Acthar Gel, which has been shown in controlled clinical trials to be effective in speeding the resolution of acute MS attacks.
Tags: shot
arm
prove
earnings
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||